Revenue Recognition Segment revenue by major payor (Tables)

9 Months Ended

Sep. 30, 2024

Disaggregation of Revenue [Table Text Block]

The following tables summarize the Company's segment revenues by primary payor source:


	Three months ended September 30, 2024						Three months ended September 30, 2023
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,641,645	$		$	1,641,645	$	1,515,860	$		$	1,515,860
Medicaid and Managed Medicaid	216,664				216,664		207,327				207,327
Other government	86,680		196,257		282,937		90,549		128,980		219,529
Commercial	954,807		58,648		1,013,455		965,331		68,192		1,033,523
Other revenues:
Medicare and Medicare Advantage			104,217		104,217				137,149		137,149
Medicaid and Managed Medicaid			(25)		(25)				331		331
Commercial			3,735		3,735				16,063		16,063
Other(1)	6,204		13,496		19,700		6,239		11,832		18,071
Eliminations of intersegment revenues	(16,140)		(2,598)		(18,738)		(24,289)		(2,232)		(26,521)
Total	$	2,889,860	$	373,730	$	3,263,590	$	2,761,017	$	360,315	$	3,121,332


	Nine months ended September 30, 2024						Nine months ended September 30, 2023
	U.S. dialysis		Other - Ancillary services		Consolidated		U.S. dialysis		Other - Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	4,760,340	$		$	4,760,340	$	4,538,264	$		$	4,538,264
Medicaid and Managed Medicaid	641,738				641,738		629,118				629,118
Other government	249,605		518,565		768,170		265,119		376,530		641,649
Commercial	2,833,263		191,212		3,024,475		2,676,758		183,578		2,860,336
Other revenues:
Medicare and Medicare Advantage			304,760		304,760				317,624		317,624
Medicaid and Managed Medicaid			816		816				1,296		1,296
Commercial			20,875		20,875				20,888		20,888
Other(1)	18,224		44,165		62,389		18,822		38,108		56,930
Eliminations of intersegment revenues	(53,528)		(9,168)		(62,696)		(66,698)		(5,007)		(71,705)
Total	$	8,449,642	$	1,071,225	$	9,520,867	$	8,061,383	$	933,017	$	8,994,400

(1) Consists primarily of management service fees in the Company's U.S. dialysis business and research fees, management fees, and other non-patient service revenues in the Other - ancillary services businesses.